Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-7.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in cellular aldehyde metabolic process.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-4 and alh-5.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in lipid metabolic process. Is an ortholog of C. elegans alh-11.
Predicted to enable lactoylglutathione lyase activity; metal ion binding activity; and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-1.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in cellular aldehyde metabolic process. Is an ortholog of C. elegans alh-5.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in cellular aldehyde metabolic process. Is an ortholog of C. elegans alh-4 and alh-5.
Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Immunoglobulin E-set; Arrestin C-terminal-like domain; Arrestin-like, C-terminal; Arrestin-like, N-terminal; and Arrestin (or S-antigen), C-terminal domain.
Predicted to enable NAD binding activity; NADP binding activity; and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in glucose metabolic process. Is an ortholog of C. elegans gpd-2 and gpd-3.